CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¾ÈÈñÁ¤
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : »êºÎÀΰúº´¸®, ³­¼Òº´¸®, À¯¹æº´¸®, ºÐÀÚº´¸®
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
75 (±¹³»)SCI Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004
74 (±¹³»)KCI 1Çü ´ç´¢º´ ¿©¾Æ¿¡¼­ °£ ±Û¸®ÄÚ°ÕÁõ¿¡ ÀÇÇÑ °£ ±â´ÉÀÌ»ó 1·Ê
73 (±¹¿Ü)SCIE Association of the XRCC1 Gene Polymorphisms in Patients with stomach Cancer
72 (±¹¿Ü)SCI Proteomic Identification of Overexpressed PRDX 1 and Its Clinical Implications in Ovarian Carcinoma
71 (±¹³»)KCI ¿Ü»ó ÈÄ ¹ß»ýÇÑ ÆÄÄ¡´Ï Á¾¾çÀÇ ÃÊÀ½ÆÄ ¼Ò°ß: Áõ·Ê º¸°í
70 (±¹³»)SCIE A case of ovarian microinvasive mucinous carcinoma and co-existent angiosarcoma
69 (±¹³»)KCI urachal actinomyocosis: CT findings ih two patients
68 (±¹³»)±âŸ Àڱ󻸷¾ÏÀÇ Ä¡·á ÈÄ ·çƾ ÃßÀû°Ë»ç ¹æ¹ýÀ¸·Î¼­ FDG-PET/CTÀÇ À¯¿ë¼º
67 (±¹³»)SCIE The Loss of E-cadherin is Associated with the Epigenetic Alteration of CDH1 in Breast Cancer and it is also Associated with an Abnormal ¥â-catenin Expression in Lobular Carcinoma
66 (±¹¿Ü)±âŸ Clinicopathologic significance of cyclin A, p27 and Skp2 in ovarian epithelial tumors
ÀÌÀüÆäÀÌÁö À̵¿ 21 22 23 24 25 26 27 28 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729